Homo sapiens Protein: RTEL1 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||
InnateDB Protein | IDBP-86837.6 | ||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||
Gene Symbol | RTEL1 | ||||||||||||||||||||
Protein Name | Regulator of telomere elongation helicase 1 | ||||||||||||||||||||
Synonyms | |||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||
Ensembl Protein | ENSP00000359035 | ||||||||||||||||||||
InnateDB Gene | IDBG-544022 (RTEL1) | ||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||
Function | ATP-dependent DNA helicase implicated in telomere-length regulation, DNA repair and the maintenance of genomic stability. Acts as an anti-recombinase to counteract toxic recombination and limit crossover during meiosis. Regulates meiotic recombination and crossover homeostasis by physically dissociating strand invasion events and thereby promotes noncrossover repair by meiotic synthesis dependent strand annealing (SDSA) as well as disassembly of D loop recombination intermediates. Also disassembles T loops and prevents telomere fragility by counteracting telomeric G4-DNA structures, which together ensure the dynamics and stability of the telomere. {ECO:0000255HAMAP- Rule:MF_03065, ECO:0000269PubMed:18957201, ECO:0000269PubMed:23453664, ECO:0000269PubMed:24009516}. | ||||||||||||||||||||
Subcellular Localization | Nucleus {ECO:0000255HAMAP-Rule:MF_03065}. Note=Colocalizes with PCNA within the replication foci in S-phase cells. {ECO:0000255HAMAP-Rule:MF_03065}. | ||||||||||||||||||||
Disease Associations | Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]: A form of dyskeratosis congenita, a rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy. DKCB5 is characterized by onset of bone marrow failure and immunodeficiency in early childhood. Most patients also have growth and developmental delay and cerebellar hypoplasia, consistent with a clinical diagnosis of Hoyeraal-Hreidarsson syndrome. {ECO:0000269PubMed:23329068, ECO:0000269PubMed:23453664, ECO:0000269PubMed:23591994, ECO:0000269PubMed:23959892, ECO:0000269PubMed:24009516}. Note=The disease is caused by mutations affecting the gene represented in this entry. RTEL1 mutations have also been found in patients with a dyskeratosis congenita-like phenotype consisting of one feature of dyskeratosis congenita and short telomeres, in the absence of the typical DKC diagnostic triad (PubMed:23329068). {ECO:0000269PubMed:23329068}.Dyskeratosis congenita, autosomal dominant, 4 (DKCA4) [MIM:615190]: A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy. {ECO:0000269PubMed:23329068}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||
Comments | |||||||||||||||||||||
Interactions | |||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 8 experimentally validated interaction(s) in this database.
|
||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||
PDB ID | |||||||||||||||||||||
InterPro |
IPR006554
Helicase-like, DEXD box c2 type IPR006555 ATP-dependent helicase, C-terminal IPR010614 DEAD2 IPR013020 DNA helicase (DNA repair), Rad3 type IPR014013 Helicase, superfamily 1/2, ATP-binding domain, DinG/Rad3-type IPR027417 P-loop containing nucleoside triphosphate hydrolase |
||||||||||||||||||||
PFAM |
PF13307
PF06733 |
||||||||||||||||||||
PRINTS | |||||||||||||||||||||
PIRSF | |||||||||||||||||||||
SMART |
SM00488
SM00491 |
||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||
Modification | |||||||||||||||||||||
Cross-References | |||||||||||||||||||||
SwissProt | Q9NZ71 | ||||||||||||||||||||
PhosphoSite | PhosphoSite-Q9NZ71 | ||||||||||||||||||||
TrEMBL | |||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||
Entrez Gene | 51750 | ||||||||||||||||||||
UniGene | Hs.743461 | ||||||||||||||||||||
RefSeq | NP_057518 | ||||||||||||||||||||
HUGO | HGNC:15888 | ||||||||||||||||||||
OMIM | 608833 | ||||||||||||||||||||
CCDS | CCDS13531 | ||||||||||||||||||||
HPRD | 15281 | ||||||||||||||||||||
IMGT | |||||||||||||||||||||
EMBL | AB029011 AF217795 AF217796 AK000485 AK299332 AK302508 AK304798 AL080127 AL353715 CH471077 | ||||||||||||||||||||
GenPept | AAF33687 AAF35243 BAA83040 BAA91197 BAG61337 BAG63785 BAG65548 CAB45725 EAW75238 EAW75239 EAW75240 EAW75241 EAW75245 | ||||||||||||||||||||